Prexige Approval Status
- FDA approved: No
- Brand name: Prexige
- Generic name: lumiracoxib
- Company: Novartis AG
- Treatment for: Osteoarthritis
Prexige (lumiracoxib) is a COX-2 inhibitor under review for the once-daily treatment of patients suffering from osteoarthritic pain. Although Prexige is currently approved in more than 50 countries, it is unlikely the painkiller will gain FDA approval.
Development Status and FDA Approval Process for Prexige
|Sep 27, 2007||Prexige Receives "Not Approvable" Letter in the US Despite Being One of the Most Studied COX-2 Inhibitors|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.